The report “Hemodialysis and Peritoneal Dialysis Market Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User (In-center, Hospital, Home) – Global Forecast to 2021″, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Browse 140 market data tables and 68 figures spread through 274 pages and in-depth TOC on “Hemodialysis and Peritoneal Dialysis Market“.
http://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html
The growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population, preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services. However, a number of product recalls and the risks & complications associated with dialysis are restricting the growth of this market to a certain extent. North America and Western European regions are mature markets for hemodialysis and peritoneal dialysis devices. However, developing regions such as Asia-Pacific (including China, India, Brazil, and Taiwan) and Latin America are expected to grow at a higher rate and become new revenue-generating markets for companies in this market. The high-growth opportunities in the Asia-Pacific and Latin American regions can be attributed to the increasing number of dialysis centers, improving reimbursement scenario, and government initiatives.
In the Asia-Pacific region, the hemodialysis and peritoneal dialysis market in India is estimated to grow at the highest CAGR in the coming five years. High prevalence rate of ESRD and CKD in the country, rapid increase in the number of dialysis patients is due to the increasing prevalence of diabetes and hypertension (which is the major cause of ESRD), government investments for the development of the country’s healthcare infrastructure are leading to growth in the number of dialysis service centers in India; thereby, rising the demand for dialysis products and services in the country. In addition, increased government funding is also motivating private investors to make huge investments in India’s healthcare system. Moreover, the presence of a large patient population, growing income levels, and rising prevalence of kidney diseases are fueling the growth of the hemodialysis and peritoneal dialysis market in India. Other Asian countries such as China, Brazil, and Taiwan are also expected to witness high growth in the forecast period.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=1279
Development of low cost and user-friendly dialysis products reduces the disparities in access to the dialysis treatment in emerging countries where the reimbursement for dialysis treatment is poor. Thus, the increasing demand for low-cost and user-friendly dialysis products in developing countries offers high growth opportunities to market players. Several companies such as Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), B. Braun Melsungen AG (Germany) and are investing in this high-growth market to gain more profits and increase their shares.
